Skip to content
healthcare.dev
Get a free key

BUDDATE REGES INTENSIVE TREATMENT

NDC 71173-3000, Butylene Glycol, Hydrogenated Coconut Oil, Butyrospermum Parkii (Shea) Butter, Palmitoyl Tripeptide-1, Palmitoyl Tetrapeptide-7, cream, from BUDDATE Co Ltd.

Product NDC
71173-3000
Status
Listed
Labeler
BUDDATE Co Ltd
Dosage form
CREAM
Route
TOPICAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED DRUG OTHER
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71173-3000 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PALMITOYL TETRAPEPTIDE-7.000006 g/100mL
  • SHEA BUTTER3 g/100mL
  • PALMITOYL TRIPEPTIDE-1.000006 g/100mL
  • BUTYLENE GLYCOL5.57 g/100mL
  • HYDROGENATED COCONUT OIL4 g/100mL
Package NDCNDC-11Package
71173-3000-17117330000170 mL in 1 TUBE (71173-3000-1)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 71173-3000 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71173-3000 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71173-3000. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.